Refocusing on Medication Safety: Best Practices for Injection Safety
We learned a lot navigating our way through the global COVID-19 pandemic and as we define what will become the new normal it is imperative that medication safety efforts remain in focus. Healthcare practitioners have steered through disruptions in supplies, medications, personal protective equipment, and more, and continue to cope with staffing challenges and other stressors while striving to provide optimal patient care. Additionally, more than 90% of hospitalized patients receive some form of intravenous (IV) therapy, either by infusion or IV push administration. IV medications are known to be clinically advantageous due to their immediate therapeutic effect and ability to support plasma drug levels, and patients being treated for COVID-19 often require multiple high-alert medications. Unfortunately, these practices are not without risk.
With harmful outcomes at stake, ISMP believes it is essential to provide healthcare practitioners with relevant information to assist them in identifying and managing the risks.
This webinar will focus on the challenges of the global COVID-19 pandemic, how practitioners can prevent medication errors despite this disruption, how to refocus on best practices related to IV push medications in adults, and how these strategies can have additional workflow benefits.
Pharmacists, Nurses, CRNAs, Anesthesiologists, PAs
Medication Safety Officers
Pharmacy and Anesthesia Technicians
Leaders in Pharmacy and Nursing
Following completion of this activity, participants will be able to:
Identify how stressors, such as the COVID-19 pandemic, challenge medication safety efforts.
Considering pandemic-related disruptions, list strategies to prevent medication errors, including the use of ready-to-administer preparations.
Describe three best practices for the use of IV push medications.
Explain how best practices for IV push medications can provide additional workflow benefits.
Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP
Michelle Mandrack, MSN, RN, Director of Consulting Services, ISMP
This activity is funded by Fresenius Kabi.
Release Date: December 22, 2021
Expiration Date: December 22, 2023
This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-286-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This activity has been approved for up to 1.25 California State Nursing contact hours by the provider, Debora Simmons, who is approved by the California Board of Registered Nursing, Provider Number CEP 13677. Credit will only be issued to individuals that are individually registered and attend the entire program.